Alpa Laboratories (NSE:ALPA) Cyclically Adjusted Revenue per Share: ₹53.92 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ALPA Alpa Laboratories Ltd NSE:ALPA
73 GF Score
Price ₹67.17
GF Value ₹93.07
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Alpa Laboratories Cyclically Adjusted Revenue per Share?

Alpa Laboratories NSE:ALPA +0.54% 73 Cyclically Adjusted Revenue per Share is ₹53.92 as of Mar. 2026. GuruFocus rates NSE:ALPA with a GF Score™ of 73/100 and a GF Value™ of ₹93.07 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Alpa Laboratories's adjusted revenue per share for the three months ended in Mar. 2026 was ₹14.921. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹53.92 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Alpa Laboratories's average Cyclically Adjusted Revenue Growth Rate was 4.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 3.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Alpa Laboratories was 3.50% per year. The lowest was 3.50% per year. And the median was 3.50% per year.

As of today (2026-07-25), Alpa Laboratories's current stock price is ₹67.17. Alpa Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ₹53.92. Alpa Laboratories's Cyclically Adjusted PS Ratio of today is 1.25.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Alpa Laboratories was 2.62. The lowest was 0.96. And the median was 1.74.


Alpa Laboratories  (NSE:ALPA) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Alpa Laboratories's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=67.17/53.92
=1.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Alpa Laboratories was 2.62. The lowest was 0.96. And the median was 1.74.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Alpa Laboratories Cyclically Adjusted Revenue per Share Related Terms


Alpa Laboratories Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Alpa Laboratories's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpa Laboratories Cyclically Adjusted Revenue per Share Chart

Alpa Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 48.41 49.62 51.10 53.92

Alpa Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51.10 52.25 52.94 53.67 53.92

NSE:ALPA vs ZTS, UTHR: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Alpa Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpa Laboratories Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alpa Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Alpa Laboratories's Cyclically Adjusted PS Ratio falls into.


NSE:ALPA
73GF Score
Alpa Laboratories Ltd NSE:ALPA
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpa Laboratories Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Alpa Laboratories's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=14.921/164.2724*164.2724
=14.921

Current CPI (Mar. 2026) = 164.2724.

Alpa Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 4.786 94.103 8.355
201409 9.075 96.780 15.404
201412 6.543 96.780 11.106
201503 6.716 97.163 11.355
201506 3.927 99.841 6.461
201509 5.957 101.753 9.617
201603 0.000 102.518 0.000
201703 0.000 105.196 0.000
201803 0.000 109.786 0.000
201809 7.173 115.142 10.234
201812 12.340 115.142 17.605
201903 6.538 118.202 9.086
201906 9.648 120.880 13.111
201909 11.175 123.175 14.904
201912 11.504 126.235 14.970
202003 18.836 124.705 24.812
202006 7.760 127.000 10.037
202009 11.559 130.118 14.593
202012 15.739 130.889 19.753
202103 11.298 131.771 14.085
202106 14.933 134.084 18.295
202109 12.492 135.847 15.106
202112 13.937 138.161 16.571
202203 11.113 138.822 13.150
202206 10.699 142.347 12.347
202209 6.705 144.661 7.614
202212 12.965 145.763 14.611
202303 13.767 146.865 15.399
202306 10.191 150.280 11.140
202309 15.388 151.492 16.686
202312 13.142 152.924 14.117
202403 10.743 153.035 11.532
202406 10.183 155.789 10.738
202409 11.875 157.882 12.356
202412 12.426 158.323 12.893
202503 17.851 157.552 18.612
202506 9.078 159.755 9.335
202509 11.670 162.289 11.813
202512 13.738 163.281 13.821
202603 14.921 164.272 14.921

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹53.92 mean?
Alpa Laboratories (NSE:ALPA) has a Cyclically Adjusted Revenue per Share of ₹53.92 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Alpa Laboratories and its competitors.
Is Alpa Laboratories' Cyclically Adjusted Revenue per Share too high?
Alpa Laboratories' current Cyclically Adjusted Revenue per Share is ₹53.92. Overall, Alpa Laboratories has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alpa Laboratories' Cyclically Adjusted Revenue per Share compare to ZTS and UTHR?
Alpa Laboratories' Cyclically Adjusted Revenue per Share of ₹53.92 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Alpa Laboratories and its competitors. Alpa Laboratories's current Cyclically Adjusted Revenue per Share is ₹53.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Alpa Laboratories (NSE:ALPA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹93.07, compared to a current price of ₹67.17 — trading 27.8% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹53.92. Alpa Laboratories' overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Alpa Laboratories (NSE:ALPA), the current Cyclically Adjusted Revenue per Share is ₹53.92 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alpa Laboratories (NSE:ALPA) Overvalued in 2026?

Based on GuruFocus' analysis, Alpa Laboratories stock appears to be undervalued. The current stock price of ₹67.17 is trading 27.8% below its estimated GF Value™ of ₹93.07. GuruFocus considers Alpa Laboratories to be Modestly Undervalued.

Key valuation signals for NSE:ALPA:

  • Cyclically Adjusted Revenue per Share: ₹53.92
  • GF Value™: ₹93.07 vs. price of ₹67.17 (27.8% below fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the NSE:ALPA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alpa Laboratories Business Description

Other Exchanges 532878:India
Address 33/2, A.B. Road, Pigdamber, Rau, Indore, MP, IND, 453446
Alpa Laboratories Ltd is an India-based pharmaceutical company. It operates in the drug and chemical business segment. The company manufactures and markets pharmaceuticals and related products. It sells products like liquid injection, dry powder injection, tablets, capsules, and ointments.
73GF Score

Get the complete analysis for NSE:ALPA

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹67.17
Price
₹93.07
GF Value